Companies
- Companies
- Browse
Companies
LFB is a fully integrated pharmaceutical company exclusively dedicated to therapeutic proteins. LFB has developed a proprietary platform to create and develop highly cytotoxic MAb's More
Contract-manufacturer for injectable ampoules, solid forms, packaging, syrups & suppositories More
The company positions itself as a distributor for API's and hospital specialty compounds: ATU's, generic portfolio for oncology, anti-emesis, pain management as well as intensive care . More
Biovector Therapeutics is a drug delivery company which is focussed on developing innovative delivery solutions (the BIOVECTORtm SYSTEMS) to enhance/enable the acceptance/delivery/efficacy of drugs. More
• Address unmet medical needs in infectious diseases and cancer, using innovative therapeutic protein variants identified from a proprietary and original use of natural human genetic variability More
Related Reports
Market Research Reports provided by reports.iptechex.com
May 2011 - 15 pages - $250
Jul 2011 - 39 pages - $5,700
Dec 2010 - 37 pages - $500
Feb 2011 - 42 pages - $5,700
Jan 2010 - $75
Jan 2011 - 34 pages - $500
Nov 2010 - 40 pages - $500
Mar 2009 - 21 pages - $995
May 2011 - 15 pages - $250
May 2010 - 40 pages - $995
Your selection
Browse By
- Industry sector
- Academic/Research
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Non-profit org./Government
- Pharmaceutical
- Research tools
- Service
- Therapeutic target
- Adoptive immunotherapy
- Amyloidosis
- Autoimmune disease (non-specific)
- Chronic fatigue syndrome
- Chronic granulomatous disease
- Chronic immunosuppression
- Gout
- Graft versus host disease
- HIV/AIDS
- Immune disorder (non-specific)
- Immune thrombocytopenic purpura
- Immunomodulation
- Immunostimulation
- Immunosuppression
- Lupus erythematosis
- Myalgic encephalomyelitis
- Myasthenia gravis
- Neoplastic disease
- Organ transplant rejection
- Rheumatoid arthritis
- Servere combined immunodeficency
- Sjogren's syndrome
- Systemic sclerosis
- Transplant rejection
- Xenotransplantation
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us